Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
Go back to Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results| (NASDAQ: CNTX) | Delayed: 0.47 -0.03 (6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $ | |||
| Open | $0.49 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.45 | EPS | $ | |||
| Volume | 3,761,465 | |||||
| (NASDAQ: CNTX) | Delayed: 0.47 -0.03 (6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $ | |||
| Open | $0.49 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.45 | EPS | $ | |||
| Volume | 3,761,465 | |||||

